Featured
April 02, 2026
FDA approves Eli Lilly’s Foundayo™ (orforglipron), the first daily GLP-1 weight loss pill with ZERO food or water restrictions. Read
Read story
FDA approves Eli Lilly’s Foundayo™ (orforglipron), the first daily GLP-1 weight loss pill with ZERO food or water restrictions. Read
Read story